Preclinical Development Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preclinical Development Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preclinical Development Program Today - Breaking & Trending Today

SCYNEXIS Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Published: August 15, 2023

SCYNEXIS reported the closing of an exclusive license agreement with GSK for BREXAFEMME® (Ibrexafungerp Tablets). SCYNEXIS received an upfront pay...

Source: businessinsider.com

Related Topics:

Irina KofflerDavid AnguloHansoh PharmaTriterpenoid AntifungalsPreclinical Development ProgramEuropean CongressExchange CommissionGlobe Newswire Scynexis IncChina National Medical Products AdministrationHansoh Pharmaceutical Group CompanyDrug AdministrationScynexis IncIbrexafungerp TabletsNew Drug ApplicationNational Medical Products AdministrationChief Executive OfficerHansoh Pharmaceutical Group Company LimitedScientific PresentationsAnnual European CongressClinical MicrobiologyInfectious DiseasesLicense AgreementHercules CapitalSilicon Valley Bridge BankPrivate Securities Litigation Reform Act

SCYNEXIS Reports Second Quarter 2023 Financial Results and Provides Corporate Update - SCYNEXIS (NASDAQ:SCYX)

Published: August 14, 2023

SCYNEXIS reported the closing of an exclusive license agreement with GSK for BREXAFEMME® (Ibrexafungerp Tablets). SCYNEXIS received an upfront payment of $90 million upon deal close.SCYNEXIS announced the

Source: benzinga.com

Related Topics:

David AnguloIrina KofflerHansoh PharmaTriterpenoid AntifungalsPreclinical Development ProgramHansoh Pharmaceutical Group CompanyExchange CommissionScynexis IncDrug AdministrationEuropean CongressGlobe Newswire Scynexis IncChina National Medical Products AdministrationIbrexafungerp TabletsNew Drug ApplicationNational Medical Products AdministrationChief Executive OfficerHansoh Pharmaceutical Group Company LimitedScientific PresentationsAnnual European CongressClinical MicrobiologyInfectious DiseasesLicense AgreementHercules CapitalSilicon Valley Bridge BankPrivate Securities Litigation Reform Act